USD 145.14
(-0.83%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 383.73 Million USD | 0.33% |
2022 | 382.47 Million USD | 0.03% |
2021 | 382.37 Million USD | 41.2% |
2020 | 270.81 Million USD | 272.86% |
2019 | 72.63 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 9.69 Million USD | -49.89% |
2014 | 19.35 Million USD | 10.57% |
2013 | 17.5 Million USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 156.61 Million USD | -59.16% |
2024 Q1 | 383.51 Million USD | -0.06% |
2024 Q3 | 157.12 Million USD | 0.33% |
2023 Q3 | 383.78 Million USD | -0.02% |
2023 Q1 | 383.24 Million USD | 0.2% |
2023 Q2 | 383.88 Million USD | 0.17% |
2023 Q4 | 383.73 Million USD | -0.01% |
2023 FY | 383.73 Million USD | 0.33% |
2022 Q4 | 382.47 Million USD | -0.01% |
2022 Q2 | 382.53 Million USD | 0.07% |
2022 Q3 | 382.5 Million USD | -0.01% |
2022 Q1 | 382.26 Million USD | -0.03% |
2022 FY | 382.47 Million USD | 0.03% |
2021 Q1 | 360.51 Million USD | 33.12% |
2021 FY | 382.37 Million USD | 41.2% |
2021 Q4 | 382.37 Million USD | 0.0% |
2021 Q3 | 382.37 Million USD | 2.68% |
2021 Q2 | 372.38 Million USD | 3.29% |
2020 Q3 | 266.11 Million USD | 3.25% |
2020 Q4 | 270.81 Million USD | 1.77% |
2020 FY | 270.81 Million USD | 272.86% |
2020 Q1 | 72.91 Million USD | 0.4% |
2020 Q2 | 257.73 Million USD | 253.47% |
2019 Q4 | 72.63 Million USD | -9.5% |
2019 Q1 | 12.17 Million USD | 0.0% |
2019 Q3 | 80.25 Million USD | 0.49% |
2019 Q2 | 79.86 Million USD | 556.04% |
2019 FY | 72.63 Million USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q4 | - USD | -100.0% |
2016 Q2 | 5.28 Million USD | -29.56% |
2016 Q1 | 7.5 Million USD | -22.61% |
2016 FY | - USD | -100.0% |
2016 Q3 | 3.03 Million USD | -42.51% |
2015 Q1 | 22.34 Million USD | 15.46% |
2015 Q2 | 20.93 Million USD | -6.31% |
2015 FY | 9.69 Million USD | -49.89% |
2015 Q4 | 9.69 Million USD | -18.24% |
2015 Q3 | 11.85 Million USD | -43.35% |
2014 Q1 | 17.5 Million USD | 0.0% |
2014 FY | 19.35 Million USD | 10.57% |
2014 Q4 | 19.35 Million USD | 0.0% |
2014 Q2 | 17.5 Million USD | 0.0% |
2013 FY | 17.5 Million USD | 0.0% |
2013 Q4 | 17.5 Million USD | 0.0% |
2013 Q3 | 17.5 Million USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 97.582% |
Allurion Technologies Inc. | 41.85 Million USD | -816.783% |
Artivion, Inc. | 359.34 Million USD | -6.789% |
Avanos Medical, Inc. | 209.1 Million USD | -83.519% |
Butterfly Network, Inc. | 25.02 Million USD | -1433.296% |
Butterfly Network, Inc. | 25.02 Million USD | -1433.296% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 72.705% |
Boston Scientific Corporation | 9.49 Billion USD | 95.957% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 61.288% |
Edwards Lifesciences Corporation | 694.9 Million USD | 44.778% |
Paragon 28, Inc. | 112.03 Million USD | -242.531% |
Globus Medical, Inc. | 520.4 Million USD | 26.262% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -1444.466% |
Integer Holdings Corporation | 1.04 Billion USD | 63.136% |
Medtronic plc | 26.04 Billion USD | 98.527% |
Nevro Corp. | 221.82 Million USD | -72.99% |
Owlet, Inc. | 15.21 Million USD | -2421.937% |
Penumbra, Inc. | 234.34 Million USD | -63.751% |
Vicarious Surgical Inc. | 14.83 Million USD | -2487.23% |
Smith & Nephew plc | 3.08 Billion USD | 87.557% |
Sonendo, Inc. | 40.35 Million USD | -851.0% |
STERIS plc | 3.38 Billion USD | 88.657% |
Stryker Corporation | 12.99 Billion USD | 97.047% |
Vapotherm, Inc. | 112.39 Million USD | -241.428% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 93.599% |